AHPA has released updates to four botanicals via the online Botanical Safety Handbook 2nd ed. AHPA members can obtain a hard copy or an annual individual subscription to the online Botanical Safety Handbook for $95.00, with multi-user rates available for companies needing expanded access. Information about hard copy purchases and subscriptions can be found on the AHPA website.
The American Herbal Products Association (AHPA) Foundation for Education and Research on Botanicals (AHPA ERB Foundation) has committed to funding a five-year harvest impact study on goldenseal (Hydrastis canadensis) led by principal investigator Katie Commender, Agroforestry Program Director, Appalachian Sustainable Development.
AHPA President Michael McGuffin will be a panelist for the breakout session “Implications of Prop. 65's proposed regulations regarding Cannabis and THC in products” during the September 27th Prop.65 Clearinghouse Annual Conference.
The hybrid 2021 AOAC INTERNATIONAL Annual Meeting & Exposition took place August 27 – September 2, 2021 at the Sheraton Boston Hotel in Boston, Massachusetts, USA, as well as virtually online. Virtual registration and the virtual meeting platform are open through September 30, 2021.
Doug Gansler, the Chair of the state Attorney General practice at Cadwalader, Wickersham & Taft and the former two-term Maryland Attorney General and President of the National Association of Attorneys General, will present an exclusive update to AHPA members on relevant enforcement and policy priority updates of the state Attorneys General in regard to supplements.
On September 1, 2021, AHPA submitted comments to the Senate sponsoring offices for the “Cannabis Administration and Opportunity Act” (CAOA) Discussion Draft.
The September 2021 AHPA Report includes: AHPA Webinar: Claims Substantiation; AHPA Congress on Immune Supplements; NDIN for "full-spectrum hemp extracts"; and more!
The U.S. Food and Drug Administration (FDA) has called for Congress to require mandatory product listing (MPL) for all dietary supplements in the U.S. marketplace. In its 2021 budget request, FDA stated that this concept would “require all products marketed as ‘dietary supplements’ to be listed with FDA and give FDA authority to act against non-compliant products and the manufacturers and/or distributors of such products”. AHPA has received reports that MPL legislation may soon be proposed in the U.S. Congress. As the debate over MPL continues to develop, and as part of his “Short Legal Briefs” series, Informa Markets editor Josh Long has conducted a pair of interviews with major dietary supplement industry figures delving into the cases for and against MPL.
In addition to the recent update to the AHPA guidance on Good agricultural and collection practices and good manufacturing practices for botanical materials (AHPA GACP-GMP) addressing prevention of pyrrolizidine alkaloid (PA) contamination, AHPA has developed educational resources that finished product marketers and botanical ingredient companies can provide to their supply chains to help educate farm managers and workers about best practices for avoidance of PA contamination.
Through a coordinated effort, several parties with long-standing engagement with and commitment to herbs and herbalism prevented consumer confusion concerning the word “herbalist” by opposing the use of the term as a trademark by an entity not associated with herbalists.
2021 Annual Fund Sponsors
AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.